Vision Fund investment portfolio company Hexagon Bio's logo

Hexagon Bio is identifying novel medicines encoded in the global metagenome and brings them to patients.

Leadership
Maureen Hillenmeyer
Fund
SVF2
Status
Private
Sector
Health Tech
Region
Americas